# Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement

> **NCT04888221** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 66 (estimated)

## Conditions studied

- Giant Cell Arteritis
- Neurovascular Disorder

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04888221
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-24
- **Primary completion:** 2025-01-29
- **Final completion:** 2025-08-13
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04888221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04888221, "Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04888221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*